Summary
Serologic testing for human immunodeficiency virus type 1 (HIV-1) is currently based on enzyme linked immunosorbent assay (ELISA) as screening method. Positive ELISA-results have to be confirmed by at least one second procedure such as Western blotting or immunofluorescence. To obtain new diagnostic reagents for confirmatory testing, we expressed viral antigens in procaryotic systems. Peptides representing epitopes of structural core (gag)- and envelope (env)-proteins of HIV were produced inE. coli as stable immunogenic β-galactosidase fusion proteins. Recombinant proteins were taken for immunoblot-assays. The results of Western blotting with those fusion proteins were in general comparable with conventional ELISA, immunofluorescence, immunoblot with cell-culture derived virus and commercially available ELISA tests based on recombinant proteins. Immunoblots using recombinant transmembrane protein (gp41) derived polypeptide were more sensitive than the conventional procedure with purified virion proteins. Western blotting with recombinant fusionproteins provide reliable and inexpensive serodiagnostics without handling of infectious cell cultures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- core- (gag-) Proteine:
-
Innere Virus-Strukturproteine
- HIV-I:
-
Humanes Immundefizienz-Virus Typ 1
- ELISA:
-
Enzyme linked immunosorbent assay
- enve- lope- (env-) Proteine:
-
Äußere Virus-Hüllproteine
- gp 41:
-
Glykoprotein 41
- p 24:
-
Protein 24
Literatur
Bröker M (1986) Vectors for regulated high-level expression of proteins fused to truncated forms ofescherichia coli β-galactosidase. Gene Anal Techn 3:53–57
Certa U, Bannwarth W, Stüber D, Gentz R, Lanzer M, Le Grice S, Guillot F, Wendler I, Hunsmann G, Bujard H, Mous J (1986) Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individuals. EMBO J 5:3051–3056
Dowbenko DJ, Bell JR, Benton ChV, Groopman JE, Nguyen H, Vetterlein D, Capon DJ, Lasky LA (1985) Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent. Proc Natl Acad Sci USA 82:7748–7752
Frösner GG, Erfle V, Mellert W, Helmann R (1987) Diagnostic significance of quantitative determination of HIV antibody specific for envelope and core proteins. Lancet I:159–160
Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning — a laboratory manual. Cold Spring Harbor Laboratory, New York
MMWR (1986) Update: Acquired immunodeficiency syndrom — United States 35/49:757–766
Pepose JS, Rae SM, Quinn TC, Holland ON (1985) The impact of the AIDS-epidemic on corneal transplantation. Am J Opthal 100:610–613
Popovic M, Sarngadharan MQ, Read E, Gallo RC (1984) Detection, isolation, and contiuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs StF, Doran ER, Rafalski JA, Whitehorn EA, Baumeister K, Ivanhoff L, Petteway StR, Pearson ML, Lautenberger JA, Papas TS, Ghrayeb J, Chang NT, Gallo RC, Wong-Staal F (1985) Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313:277–283
Reesink HW, Huisman JG, Gonsalves M, Winkel IN, Hekker AC, Lelie PN, Schaasberg W, Aaij C, van der Does JA, Desmyter J (1986) Evaluation of six enzym immunoassays for antibody against human immunodeficiency virus. Lancet I:483–486
Salahuddin SZ, Markham PD, Redfield RR, Essex M, Groopman JE, Sarngadharan MG, McLane MF, Sliski A (1985) HTLV-III in symptom-free seronegative persons. Lancet II:1418–1420
Schüpbach J, Haller O, Vagt M, Lüthy R, Joller H, Oelz O, Popovic M, Sarngadharan MG, Gallo R (1985) Antibodies to HTLV-III in swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med 312:265–270
Schulz TF, Aschauer JM, Hengster P, Larcher C, Wachter H, Fleckenstein B, Dierich MP (1986) Envelope genederived recombinant peptide in the serodiagnosis of human immunodeficiency virus infection. Lancet I:111–112
Steimer KS, Puma JP, Power MD, Powers MA, George-Nascimento C, Stephans JC, Levy JA, Sanchez-Pescador R, Luciw PA, Barr PJ, Hallewell RA (1986) Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology 150:283–290
Towbin H, Staehelin Th, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Wang JJG, Steel S, Wisniewolski R, Yi Wang Ch (1986) Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc Natl Acad Sci USA 83:6159–6163
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lenz, A., von Hintzenstern, J., Erlwein, O. et al. Serologische AIDS-Diagnostik mit gentechnisch gewonnenen Polypeptiden des menschlichen Immundefizienz-Virus (HIV-1). Klin Wochenschr 65, 1042–1047 (1987). https://doi.org/10.1007/BF01726323
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01726323